-
SmithKline Beecham's chief scientific officer, George Poste, speaks of pharmacogenomics as the savior of the industry.
FORBES: Tailor-made drugs
-
The antidepressant gene test failed in trials, and Clinical Data sold the pharmacogenomics business.
FORBES: End Of An Era: The Last Herper-Langreth Biotech Story
-
That research was led by Prof Colin Palmer, chair of Pharmacogenomics at the University of Dundee.
BBC: Results of Tayside gene tests help find heart disease link
-
Kirk still believes that pharmacogenomics will work but says it is progressing at a much slower pace than drugs.
FORBES: End Of An Era: The Last Herper-Langreth Biotech Story
-
But it does provide a proof of concept for using genes to predict if drugs work, an idea called pharmacogenomics.
FORBES: Cholesterol Drugs Enter Genomic Age
-
It is very large and very complex, and yet you do get a sense that pharmacogenomics might have a role.
FORBES: Cholesterol Drugs Enter Genomic Age
-
But pharmacogenomics is based on replacing the blockbuster model with one that concentrates on a larger number of narrower products -- a drug, say, that benefits only 10% of arthritis sufferers.
FORBES: Tailor-made drugs
-
Their way may be made easier by novel drug-development technologies, such as pharmacogenomics, and new marketing methods, such as e-commerce, which will allow them to sell tailored drugs without the trappings of size.
ECONOMIST: Drug mergers are all the rage; but few make much sense
-
If pharmacogenomics can help to recruit those patients who should respond to the drug and rule out those who will have adverse reactions, it will rescue useful remedies that would otherwise have been discarded.
FORBES: Tailor-made drugs
-
Pharmacogenomics promises custom drugs.
FORBES: Tailor-made drugs